Christopher Thierry

Cimpl, Inc. provides information technology solutions. Its product Cimpl simplifies the task of technology expense management by connecting the complex invoice and usage data of information technology and telecom services. The company was founded by Christopher Thierry and Jeffrey Speak in 2000 and is headquartered in Lachine, Canada.

Calliditas Therapeutics France SAS is a biopharmaceutical company, which engages in the NOX therapies. Its therapeutic approach is based on a selective inhibition of NOX enzymes that amplify multiple disease processes, such as fibrosis, inflammation, pain processing, cancer development, and eurodegeneration. The firm’s platform enables the identification of orally available small molecules that selectively inhibit specific NOX enzymes. The company was founded in 2006 and is headquartered in Saint-Julien-en-Genevois, France.